OncoTargets and Therapy, Volume 16, Issue (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

OncoTargets and Therapy, Volume 16, Issue (2023)

See all volumes and issues
Vol 17, 2024 Volume 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Vol 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs

REVIEW

Review
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
Indumathy Varadarajan, Eric Pierce, Lisa Scheuing, Amy Morris, Firas El Chaer & Michael Keng
Pages: 1-16
Published online: 14 Jan 2023
AbstractforPost-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions | Full Text | References | PDF (568.2 KB)
  • 443 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
Dan Li, Xin Liu, SaiQiong Cui, DaFu Yang, Yue Zhu, Evenki Pan, Peng Yang & ZhaoXia Dai
Pages: 17-22
Published online: 18 Jan 2023
AbstractforA Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review | Full Text | References | PDF (3.1 MB)
  • 269 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Case Report
A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib
Weiming Fan, Chuan Wang, Xuefeng Zhong, Yating Zheng, Tingting Chen, Mengli Huang & Shuying Su
Pages: 23-29
Published online: 19 Jan 2023
AbstractforA Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib | Full Text | References | PDF (2.7 MB)
  • 304 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile
Sylvain Garciaz & Marie-Anne Hospital
Pages: 31-45
Published online: 19 Jan 2023
AbstractforFMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile | Full Text | References | PDF (533.9 KB)
  • 404 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
miR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression [Retraction]
Pages: 47-48
Published online: 19 Jan 2023
CitationformiR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression [Retraction] | Full Text | PDF (235 KB)
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction
Dylan M Buller, Maria Antony & Benjamin T Ristau
Pages: 49-64
Published online: 24 Jan 2023
AbstractforAdjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction | Full Text | References | PDF (1.3 MB)
  • 258 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
Kazuhito Misawa, Shinji Nakamichi, Hiroki Iida, Atsuhiro Nagano, Erika Mikami, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, Hiroki Yamaguchi & Masahiro Seike
Pages: 65-69
Published online: 24 Jan 2023
AbstractforAlectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report | Full Text | References | PDF (915.1 KB)
  • 285 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Estela Pineda, Marta Domenech, Ainhoa Hernández, Silvia Comas & Carmen Balaña
Pages: 71-86
Published online: 25 Jan 2023
AbstractforRecurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects | Full Text | References | PDF (2.1 MB)
  • 685 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
Xiangming Zhang, Kai Ni & Huijun Chen
Pages: 87-90
Published online: 25 Jan 2023
AbstractforSuccessful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report | Full Text | References | PDF (2.3 MB)
  • 183 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Case Report
Secondary Sinonasal Collision Tumor of Papillary Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma After Nasopharyngeal Carcinoma Radiotherapy: A Case Report and Literature Review of Sinonasal Collision Carcinomas
Hao Tang, Lina Wang, Wenfeng Xu, Yujuan Xu, Xianyun Li & Deyu Guo
Pages: 91-97
Published online: 11 Feb 2023
AbstractforSecondary Sinonasal Collision Tumor of Papillary Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma After Nasopharyngeal Carcinoma Radiotherapy: A Case Report and Literature Review of Sinonasal Collision Carcinomas | Full Text | References | PDF (1.5 MB)
  • 264 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward
Kanako Shinada & Shuji Murakami
Pages: 99-108
Published online: 15 Feb 2023
AbstractforNeoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward | Full Text | References | PDF (459.8 KB)
  • 357 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Ineffectiveness of Crizotinib in a Non-Small-Cell Lung Cancer with Novel ALK- LIMS1 Fusion: A Case Report
Junmei Shi, Zhaohui Jia, Zhiguo Zhou, Liyan Zhao, Qingju Meng & Yibing Liu
Pages: 109-114
Published online: 17 Feb 2023
AbstractforIneffectiveness of Crizotinib in a Non-Small-Cell Lung Cancer with Novel ALK- LIMS1 Fusion: A Case Report | Full Text | References | PDF (2.5 MB)
  • 242 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks
Pablo Mandó, Federico Waisberg, Rosario Pasquinelli, Sergio Rivero, Alexis Ostinelli & Florencia Perazzo
Pages: 115-132
Published online: 19 Feb 2023
AbstractforHER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks | Full Text | References | PDF (1.6 MB)
  • 377 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report
Meshaal Alanzi, Mohammad Abu-Tineh, Lajos Szabados, MZ Sharaf Eldean, Sali Alatasi, Ruba Y Taha & Sarah A Elkourashy
Pages: 133-139
Published online: 21 Feb 2023
AbstractforPolatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report | Full Text | References | PDF (901.8 KB)
  • 307 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CORRIGENDUM

Correction
Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect [Corrigendum]
Pages: 141-142
Published online: 01 Mar 2023
CitationforClinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect [Corrigendum] | Full Text | PDF (235 KB)
  • 133 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

EXPERT OPINION

Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article)
Salah Mohamed El Sayed
Pages: 143-155
Published online: 05 Mar 2023
AbstractforBiochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article) | Full Text | References | PDF (4.2 MB)
  • 345 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study
Guiling Li, Mingxia Cheng, Kai Hong & Yao Jiang
Pages: 157-163
Published online: 06 Mar 2023
AbstractforClinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study | Full Text | References | PDF (737.8 KB)
  • 259 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
A Review of CAR-T Therapy in Pediatric and Young Adult B-Lineage Acute Leukemia: Clinical Perspectives in Singapore
Michaela S Seng, Amandine C Meierhofer, Francesca L Lim, Shui Yen Soh & William YK Hwang
Pages: 165-176
Published online: 14 Mar 2023
AbstractforA Review of CAR-T Therapy in Pediatric and Young Adult B-Lineage Acute Leukemia: Clinical Perspectives in Singapore | Full Text | References | PDF (929.8 KB)
  • 431 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Portulacerebroside a Inhibits Adhesion, Migration, and Invasion of Human Leukemia HL60 Cells and U937 Cells through the Regulation of p38/JNK Signaling Pathway [Retraction]
Pages: 177-178
Published online: 16 Mar 2023
CitationforPortulacerebroside a Inhibits Adhesion, Migration, and Invasion of Human Leukemia HL60 Cells and U937 Cells through the Regulation of p38/JNK Signaling Pathway [Retraction] | Full Text | PDF (242.3 KB)
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date
Leticia Varella & Massimo Cristofanilli
Pages: 189-196
Published online: 23 Mar 2023
AbstractforEvaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date | Full Text | References | PDF (372.8 KB)
  • 674 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Role of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer
Jia-Wei Wang, Qing Yuan, Li Li, Kai-Hua Cao, Qi Liu, Hong-Liang Wang, Ke Hu, Xi Wu & Jing-Hai Wan
Pages: 179-187
Published online: 23 Mar 2023
AbstractforRole of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer | Full Text | References | PDF (2.9 MB)
  • 232 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel
Jiaru Hu, Qing He, Tian Tian, Na Chang & Liting Qian
Pages: 197-210
Published online: 27 Mar 2023
AbstractforTransmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel | Full Text | References | PDF (10.8 MB)
  • 230 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
CXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1α/Snail Signaling Axis [Retraction]
Pages: 211-212
Published online: 28 Mar 2023
CitationforCXCL8 Promotes Glioma Progression by Activating the JAK/STAT1/HIF-1α/Snail Signaling Axis [Retraction] | Full Text | PDF (251.9 KB)
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Matrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction]
Pages: 213-214
Published online: 29 Mar 2023
CitationforMatrine Suppresses the Migration and Invasion of NSCLC Cells by Inhibiting PAX2-Induced Epithelial-Mesenchymal Transition [Retraction] | Full Text | PDF (235.3 KB)
  • 117 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer
Revathi Badiginchala, Palanki Satya Dattatreya, Attili Venkata Satya Suresh, Sharanabasappa Somanath Nirni, Vindhya Vasini Andra, Deepak Bunger & Alok Chaturvedi
Pages: 215-225
Published online: 01 Apr 2023
AbstractforEfficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer | Full Text | References | PDF (2 MB)
  • 229 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma
Elena Simonetti, Serena Cutarella, Monica Valente, Tommaso Sani, Matteo Ravara, Michele Maio & Anna Maria Di Giacomo
Pages: 227-232
Published online: 05 Apr 2023
AbstractforFrom Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma | Full Text | References | PDF (1.8 MB)
  • 217 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction]
Pages: 233-234
Published online: 06 Apr 2023
CitationforMicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction] | Full Text | PDF (235.3 KB)
  • 140 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
Hazel M O’Sullivan, Andrew Feber & Sanjay Popat
Pages: 249-259
Published online: 07 Apr 2023
AbstractforMinimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions | Full Text | References | PDF (2.5 MB)
  • 591 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
Stefania Stella, Federica Martorana, Michele Massimino, Silvia Rita Vitale, Livia Manzella & Paolo Vigneri
Pages: 235-247
Published online: 07 Apr 2023
AbstractforPotential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far | Full Text | References | PDF (4.2 MB)
  • 358 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]
Pages: 261-262
Published online: 08 Apr 2023
CitationformiR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction] | Full Text | PDF (241.3 KB)
  • 131 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma
Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Manato Ohsawa, Ryosuke Hirohata, Nao Kitasaki & Morihito Okada
Pages: 263-273
Published online: 10 Apr 2023
AbstractforAbility of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma | Full Text | References | PDF (2.8 MB)
  • 316 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]
Pages: 275-276
Published online: 12 Apr 2023
CitationforDihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction] | Full Text | PDF (254.3 KB)
  • 131 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial–Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells [Retraction]
Pages: 277-278
Published online: 18 Apr 2023
CitationforResveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial–Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells [Retraction] | Full Text | PDF (235.2 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CORRIGENDUM

Correction
Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum]
Pages: 279-280
Published online: 20 Apr 2023
CitationforEvaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum] | Full Text | PDF (728.7 KB)
  • 154 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
MNK Proteins as Therapeutic Targets in Leukemia
Candice Mazewski & Leonidas C Platanias
Pages: 283-295
Published online: 21 Apr 2023
AbstractforMNK Proteins as Therapeutic Targets in Leukemia | Full Text | References | PDF (1.2 MB)
  • 378 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Pages: 281-282
Published online: 21 Apr 2023
CitationforLncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction] | Full Text | PDF (254.5 KB)
  • 116 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
Noa E Wijnen, Joost B Koedijk, Kim Klein, Maaike Luesink, Bianca F Goemans, C Michel Zwaan & Gertjan JL Kaspers
Pages: 297-308
Published online: 29 Apr 2023
AbstractforTreating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin | Full Text | References | PDF (1.2 MB)
  • 320 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]
Pages: 309-310
Published online: 09 May 2023
CitationforKIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction] | Full Text | PDF (238.9 KB)
  • 126 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]
Pages: 311-312
Published online: 11 May 2023
CitationforMicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction] | Full Text | PDF (237.3 KB)
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction]
Pages: 315-316
Published online: 15 May 2023
CitationforKDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction] | Full Text | PDF (239.6 KB)
  • 146 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Retraction

Retraction
LINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9 [Retraction]
Pages: 313-314
Published online: 15 May 2023
CitationforLINC00565 Enhances Proliferative Ability in Endometrial Carcinoma by Downregulating KLF9 [Retraction] | Full Text | PDF (231.5 KB)
  • 112 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib
Kuan-Chih Chen, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Gee-Chen Chang & Tsung-Ying Yang
Pages: 317-326
Published online: 17 May 2023
AbstractforThe Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib | Full Text | References | PDF (3.8 MB)
  • 164 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Circ_0005576 Promotes Malignant Progression Through miR-874/CDK8 Axis in Colorectal Cancer [Retraction]
Pages: 327-328
Published online: 18 May 2023
CitationforCirc_0005576 Promotes Malignant Progression Through miR-874/CDK8 Axis in Colorectal Cancer [Retraction] | Full Text | PDF (231.9 KB)
  • 130 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
LINC00958 Promotes the Malignancy of Nasopharyngeal Carcinoma by Sponging microRNA-625 and Thus Upregulating NUAK1 [Retraction]
Pages: 329-330
Published online: 26 May 2023
CitationforLINC00958 Promotes the Malignancy of Nasopharyngeal Carcinoma by Sponging microRNA-625 and Thus Upregulating NUAK1 [Retraction] | Full Text | PDF (261.9 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma
Ke Ma, Qianqian Guo, Xianwei Zhang & Yanxin Li
Pages: 331-345
Published online: 29 May 2023
AbstractforHigh Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma | Full Text | References | PDF (14.7 MB)
  • 153 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer
Jianlong Zhou, Juanmei Mo, Chaohui Tan, Feng Xie, Jing Liang & Wenhua Huang
Pages: 347-357
Published online: 31 May 2023
AbstractforJUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer | Full Text | References | PDF (7 MB)
  • 240 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab
Nathan El-ghazzi, Xavier Durando, Alexia Giro & Tressie Herrmann
Pages: 359-369
Published online: 02 Jun 2023
AbstractforTargeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab | Full Text | References | PDF (2.5 MB)
  • 277 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Review
Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?
Jiaqiang Wang, Hong Ge & Zhichao Tian
Pages: 385-397
Published online: 07 Jun 2023
AbstractforImmunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism? | Full Text | References | PDF (2.8 MB)
  • 214 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
Annalisa D’Avola, Katarina Kluckova, Andrew J Finch & John C Riches
Pages: 371-383
Published online: 07 Jun 2023
AbstractforSpotlight on New Therapeutic Opportunities for MYC-Driven Cancers | Full Text | References | PDF (2.1 MB)
  • 220 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells [Retraction]
Pages: 407-408
Published online: 09 Jun 2023
CitationforCCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells [Retraction] | Full Text | PDF (240.6 KB)
  • 130 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Low-Grade Ductal Carcinoma in situ Within a Fibroadenoma of the Breast: A Rare Case Report and Review of the Literature
Xi-Hao Ni, Ran An, Qian-Wen Shi & Chang-Liang Wang
Pages: 399-406
Published online: 09 Jun 2023
AbstractforLow-Grade Ductal Carcinoma in situ Within a Fibroadenoma of the Breast: A Rare Case Report and Review of the Literature | Full Text | References | PDF (3.7 MB)
  • 196 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML
Xiaotong Chen, Yanqiu Zhao, Qi Li & Shengjin Fan
Pages: 409-419
Published online: 13 Jun 2023
AbstractforSingle-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML | Full Text | References | PDF (1.2 MB)
  • 158 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
MicroRNA 628 Suppresses Migration and Invasion of Breast Cancer Stem Cells through Targeting SOS1 [Retraction]
Pages: 421-422
Published online: 19 Jun 2023
CitationforMicroRNA 628 Suppresses Migration and Invasion of Breast Cancer Stem Cells through Targeting SOS1 [Retraction] | Full Text | PDF (236.7 KB)
  • 150 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
The Important Tumor Suppressor Role of PER1 in Regulating the Cyclin–CDK–CKI Network in SCC15 Human Oral Squamous Cell Carcinoma Cells [Retraction]
Pages: 423-424
Published online: 19 Jun 2023
CitationforThe Important Tumor Suppressor Role of PER1 in Regulating the Cyclin–CDK–CKI Network in SCC15 Human Oral Squamous Cell Carcinoma Cells [Retraction] | Full Text | PDF (244.6 KB)
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
Trilok Shrivastava, Frits Van Rhee & Samer Al Hadidi
Pages: 441-464
Published online: 20 Jun 2023
AbstractforTargeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives | Full Text | References | PDF (1.7 MB)
  • 349 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
Jingya Duan, Zisen Zhang, Jinfeng Du, Jihua Zhang, Minmin Li & Canyu Li
Pages: 425-440
Published online: 20 Jun 2023
AbstractforEsomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells | Full Text | References | PDF (15.6 MB)
  • 218 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota & Masahiro Seike
Pages: 465-470
Published online: 23 Jun 2023
AbstractforRemarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report | Full Text | References | PDF (3 MB)
  • 200 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction]
Pages: 471-472
Published online: 23 Jun 2023
CitationforMicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction] | Full Text | PDF (240.3 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction]
Pages: 473-474
Published online: 26 Jun 2023
CitationforLOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction] | Full Text | PDF (237.7 KB)
  • 150 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Retraction]
Pages: 475-476
Published online: 27 Jun 2023
CitationformiR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Retraction] | Full Text | PDF (236.2 KB)
  • 101 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Retraction]
Pages: 483-484
Published online: 27 Jun 2023
CitationforThe Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Retraction] | Full Text | PDF (233.1 KB)
  • 145 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Retraction]
Pages: 477-478
Published online: 27 Jun 2023
CitationformiR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Retraction] | Full Text | PDF (231.6 KB)
  • 118 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Knockdown of Immature Colon Carcinoma Transcript-1 Inhibits Proliferation of Glioblastoma Multiforme Cells through Gap 2/Mitotic Phase Arrest [Retraction]
Pages: 479-480
Published online: 27 Jun 2023
CitationforKnockdown of Immature Colon Carcinoma Transcript-1 Inhibits Proliferation of Glioblastoma Multiforme Cells through Gap 2/Mitotic Phase Arrest [Retraction] | Full Text | PDF (232.4 KB)
  • 109 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction]
Pages: 481-482
Published online: 27 Jun 2023
CitationforPP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction] | Full Text | PDF (232.6 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases
Fei Shen, Jihe Huang, Kejia Yang & Chunhua Sun
Pages: 485-495
Published online: 29 Jun 2023
AbstractforA Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases | Full Text | References | PDF (2.9 MB)
  • 214 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction]
Pages: 497-498
Published online: 30 Jun 2023
CitationformiR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction] | Full Text | PDF (263.6 KB)
  • 103 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives
John Maher
Pages: 515-532
Published online: 03 Jul 2023
AbstractforChimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives | Full Text | References | PDF (1.6 MB)
  • 448 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population
Min Gao, Yongwen Li, Hua Huang, Yaguang Fan, Ruifeng Shi, Lianchun Su, Chen Chen, Xuanguang Li, Guangsheng Zhu, Di Wu, Peijun Cao, Hongyu Liu, Jun Chen & Shirong Kang
Pages: 499-513
Published online: 03 Jul 2023
AbstractforExploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population | Full Text | References | PDF (3.1 MB)
  • 168 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
MACC1 Promotes Angiogenesis in Cholangiocarcinoma by Upregulating VEGFA [Retraction]
Pages: 533-534
Published online: 05 Jul 2023
CitationforMACC1 Promotes Angiogenesis in Cholangiocarcinoma by Upregulating VEGFA [Retraction] | Full Text | PDF (232 KB)
  • 98 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion
Jing He, Youyuan Yao, Fei Quan, Zhongyu Lu, Jian Wang & Wen Gao
Pages: 535-540
Published online: 07 Jul 2023
AbstractforPartial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion | Full Text | References | PDF (4.6 MB)
  • 165 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
The Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction]
Pages: 543-544
Published online: 07 Jul 2023
CitationforThe Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction] | Full Text | PDF (235.8 KB)
  • 141 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Downregulation of Ribophorin II Suppresses Tumor Growth, Migration, and Invasion of Nasopharyngeal Carcinoma [Retraction]
Pages: 541-542
Published online: 07 Jul 2023
CitationforDownregulation of Ribophorin II Suppresses Tumor Growth, Migration, and Invasion of Nasopharyngeal Carcinoma [Retraction] | Full Text | PDF (233.9 KB)
  • 127 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis
Nan Zhang, Chang Liu & Wen Di
Pages: 545-558
Published online: 08 Jul 2023
AbstractforSystemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis | Full Text | References | PDF (616.3 KB)
  • 234 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy
Seiichiro Katagiri, Nahoko Furuya, Daigo Akahane, SungGi Chi, Yosuke Minami, Yuka Harada, Hironori Harada & Akihiko Gotoh
Pages: 571-576
Published online: 12 Jul 2023
AbstractforGilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy | Full Text | References | PDF (1.3 MB)
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
Abram Arnold & Apar Kishor Ganti
Pages: 559-569
Published online: 11 Jul 2023
AbstractforClinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes | Full Text | References | PDF (1 MB)
  • 236 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression [Retraction]
Pages: 581-582
Published online: 13 Jul 2023
CitationforLong Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression [Retraction] | Full Text | PDF (244.2 KB)
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Retraction]
Pages: 579-580
Published online: 13 Jul 2023
CitationforLncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Retraction] | Full Text | PDF (242.9 KB)
  • 112 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression [Retraction]
Pages: 577-578
Published online: 13 Jul 2023
CitationforLong Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression [Retraction] | Full Text | PDF (257.5 KB)
  • 109 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Identification of Enzalutamide Resistance-Related circRNA-miRNA-mRNA Regulatory Networks in Patients with Prostate Cancer [Retraction]
Pages: 583-584
Published online: 18 Jul 2023
CitationforIdentification of Enzalutamide Resistance-Related circRNA-miRNA-mRNA Regulatory Networks in Patients with Prostate Cancer [Retraction] | Full Text | PDF (235.2 KB)
  • 156 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers
Alessandro Parisi, Francesca Rossi, Chiara De Filippis, Francesco Paoloni, Cristiano Felicetti, Alex Mammarella, Federica Pecci, Alessio Lupi & Rossana Berardi
Pages: 585-613
Published online: 18 Jul 2023
AbstractforCurrent Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers | Full Text | References | PDF (2.9 MB)
  • 295 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Pages: 615-616
Published online: 19 Jul 2023
CitationforLncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction] | Full Text | PDF (223.6 KB)
  • 109 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
Haifaa Abdulhaq, Andrew Hwang & Omar Mahmood
Pages: 617-629
Published online: 20 Jul 2023
AbstractforTargeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context | Full Text | References | PDF (3.8 MB)
  • 261 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Primary Diffuse Large B-Cell Lymphoma of the Penis: A Case and Literature Review
Tiantian Yu, Lingyu Zou, Ya Wang, Cancan Luo & Li Yu
Pages: 631-638
Published online: 25 Jul 2023
AbstractforPrimary Diffuse Large B-Cell Lymphoma of the Penis: A Case and Literature Review | Full Text | References | PDF (1.6 MB)
  • 170 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Long Noncoding RNA NEAT1 Promotes Nasopharyngeal Carcinoma Progression Through Regulation of miR-124/NF-κB Pathway [Retraction]
Pages: 639-640
Published online: 26 Jul 2023
CitationforLong Noncoding RNA NEAT1 Promotes Nasopharyngeal Carcinoma Progression Through Regulation of miR-124/NF-κB Pathway [Retraction] | Full Text | PDF (252.4 KB)
  • 89 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Upregulated miR-27a-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway [Retraction]
Pages: 641-642
Published online: 26 Jul 2023
CitationforUpregulated miR-27a-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway [Retraction] | Full Text | PDF (232.5 KB)
  • 122 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
lncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcinoma [Retraction]
Pages: 643-644
Published online: 26 Jul 2023
CitationforlncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcinoma [Retraction] | Full Text | PDF (231.2 KB)
  • 105 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Intergenic Non-Protein Coding RNA 519 Promotes the Biological Activities of Tongue Squamous Cell Carcinoma by Sponging microRNA-876-3p and Consequently Upregulating MACC1 [Retraction]
Pages: 645-646
Published online: 26 Jul 2023
CitationforLong Intergenic Non-Protein Coding RNA 519 Promotes the Biological Activities of Tongue Squamous Cell Carcinoma by Sponging microRNA-876-3p and Consequently Upregulating MACC1 [Retraction] | Full Text | PDF (232.9 KB)
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Retraction]
Pages: 647-648
Published online: 26 Jul 2023
CitationforLong Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Retraction] | Full Text | PDF (233.4 KB)
  • 131 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
LncRNA XIST Depletion Prevents Cancer Progression in Invasive Pituitary Neuroendocrine Tumor by Inhibiting bFGF via Upregulation of microRNA-424-5p [Retraction]
Pages: 649-650
Published online: 31 Jul 2023
CitationforLncRNA XIST Depletion Prevents Cancer Progression in Invasive Pituitary Neuroendocrine Tumor by Inhibiting bFGF via Upregulation of microRNA-424-5p [Retraction] | Full Text | PDF (238.5 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis [Retraction]
Pages: 651-652
Published online: 01 Aug 2023
CitationforLong Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis [Retraction] | Full Text | PDF (231.2 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis [Retraction]
Pages: 655-656
Published online: 02 Aug 2023
CitationforHistone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis [Retraction] | Full Text | PDF (249.4 KB)
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
PVT1 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer via Regulating miR-148/RAB34 Signal Axis [Retraction]
Pages: 653-654
Published online: 02 Aug 2023
CitationforPVT1 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer via Regulating miR-148/RAB34 Signal Axis [Retraction] | Full Text | PDF (261.5 KB)
  • 123 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects
Yu Saida, Satoshi Watanabe & Toshiaki Kikuchi
Pages: 657-671
Published online: 02 Aug 2023
AbstractforExtensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects | Full Text | References | PDF (787.2 KB)
  • 343 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
Pages: 673-674
Published online: 02 Aug 2023
CitationforEZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction] | Full Text | PDF (237.9 KB)
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights
Annesha Chatterjee, Jordana Maria Azevedo-Martins & Matthew D Stachler
Pages: 675-687
Published online: 10 Aug 2023
AbstractforInterleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights | Full Text | References | PDF (837.8 KB)
  • 245 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Circular RNA Circ-Foxo3 Induced Cell Apoptosis in Urothelial Carcinoma via Interaction with miR-191-5p [Retraction]
Pages: 693-694
Published online: 11 Aug 2023
CitationforCircular RNA Circ-Foxo3 Induced Cell Apoptosis in Urothelial Carcinoma via Interaction with miR-191-5p [Retraction] | Full Text | PDF (239.6 KB)
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283 [Retraction]
Pages: 691-692
Published online: 11 Aug 2023
CitationforCircular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283 [Retraction] | Full Text | PDF (232.8 KB)
  • 102 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Spotlight on GOT2 in Cancer Metabolism
Samuel A Kerk, Javier Garcia-Bermudez, Kivanc Birsoy, Mara H Sherman, Yatrik M Shah & Costas A Lyssiotis
Pages: 695-702
Published online: 22 Aug 2023
AbstractforSpotlight on GOT2 in Cancer Metabolism | Full Text | References | PDF (1.5 MB)
  • 372 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
Zhaopeng Li, Deyong Bu, Xiaobin Wang, Lin Zhu, Daoyan Lei, Fengling Tang, Xianghua Sun, Cheng Chen, Xiang Ji & Song Bai
Pages: 703-721
Published online: 30 Aug 2023
AbstractforChidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis | Full Text | References | PDF (13.3 MB)
  • 179 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Recent Advances in the Management of Adverse Events Associated with Lorlatinib
Dehua Liao, Jiwen Zhang, Ting Yan, Shanshan Chen, Wei Li, Dangang Shangguan & Zhihua She
Pages: 731-738
Published online: 05 Sep 2023
AbstractforRecent Advances in the Management of Adverse Events Associated with Lorlatinib | Full Text | References | PDF (1.8 MB)
  • 213 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
microRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction]
Pages: 723-724
Published online: 05 Sep 2023
CitationformicroRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction] | Full Text | PDF (249.9 KB)
  • 90 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MYO5A Inhibition by miR-145 Acts as a Predictive Marker of Occult Neck Lymph Node Metastasis in Human Laryngeal Squamous Cell Carcinoma [Retraction]
Pages: 729-730
Published online: 05 Sep 2023
CitationforMYO5A Inhibition by miR-145 Acts as a Predictive Marker of Occult Neck Lymph Node Metastasis in Human Laryngeal Squamous Cell Carcinoma [Retraction] | Full Text | PDF (235.5 KB)
  • 84 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]
Pages: 725-726
Published online: 05 Sep 2023
CitationforBerberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction] | Full Text | PDF (237.1 KB)
  • 91 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Noncoding RNA UCA1 Promotes the Proliferation, Invasion, and Migration of Nasopharyngeal Carcinoma Cells via Modulation of miR-145 [Retraction]
Pages: 727-728
Published online: 05 Sep 2023
CitationforLong Noncoding RNA UCA1 Promotes the Proliferation, Invasion, and Migration of Nasopharyngeal Carcinoma Cells via Modulation of miR-145 [Retraction] | Full Text | PDF (235.3 KB)
  • 86 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Colon Metastasis from Pancreatic Cancer: A Case Report
Nan Meng, Ping Han, Liwei Liu, Jiqiao Liu & Jingmei Liu
Pages: 739-744
Published online: 07 Sep 2023
AbstractforColon Metastasis from Pancreatic Cancer: A Case Report | Full Text | References | PDF (2.1 MB)
  • 161 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway [Retraction]
Pages: 747-748
Published online: 11 Sep 2023
CitationforLamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway [Retraction] | Full Text | PDF (219.6 KB)
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs [Retraction]
Pages: 745-746
Published online: 11 Sep 2023
CitationforLong Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs [Retraction] | Full Text | PDF (223.1 KB)
  • 105 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction]
Pages: 749-750
Published online: 14 Sep 2023
CitationforMiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction] | Full Text | PDF (231.6 KB)
  • 87 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction]
Pages: 751-752
Published online: 15 Sep 2023
CitationforMicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction] | Full Text | PDF (233.1 KB)
  • 82 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8+T Cell Counts and Age
Yuan Wu, Xiaoli Liu, Xinhui Wang, Lihua Yu, Huiwen Yan, Yuqing Xie, Qing Pu, Xue Cai, Yaxian Kong & Zhiyun Yang
Pages: 753-766
Published online: 21 Sep 2023
AbstractforA Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8+T Cell Counts and Age | Full Text | References | PDF (6.9 MB)
  • 119 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma
Xue Gu, Xiaoli Li, Xue Zhang, Li Tong, Ran Feng, Lei Liu, Hui Sun, Qing Zhang, Tingting Bian, Jianguo Zhang, Lihua Gao, Chenxi Zhang, Jian Liu & Yifei Liu
Pages: 767-783
Published online: 22 Sep 2023
AbstractforNoncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma | Full Text | References | PDF (14.3 MB)
  • 144 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights
Mona S Abdellateif, Ahmed K Bayoumi & Mohammed Aly Mohammed
Pages: 785-799
Published online: 27 Sep 2023
Abstractforc-Kit Receptors as a Therapeutic Target in Cancer: Current Insights | Full Text | References | PDF (657.9 KB)
  • 262 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction]
Pages: 801-802
Published online: 29 Sep 2023
CitationforLoss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction] | Full Text | PDF (234.7 KB)
  • 76 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability
Michele Massimino, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Fabio Stagno, Silvia Rita Vitale, Chiara Romano, Cristina Tomarchio, Nunziatina Laura Parrinello, Livia Manzella, Francesco Di Raimondo & Paolo Vigneri
Pages: 803-816
Published online: 03 Oct 2023
AbstractforHigh BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability | Full Text | References | PDF (6.2 MB)
  • 122 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Let-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma [Retraction]
Pages: 817-818
Published online: 11 Oct 2023
CitationforLet-7c-5p Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma [Retraction] | Full Text | PDF (243.3 KB)
  • 78 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
Zhixing Xu, Haitao Xu, Xi Chen, Xiaobing Huang, Jintao Tian, Jinxi Zhao, Bohu Liu, Fengcai Shi, Jin Wu & Jun Pu
Pages: 819-837
Published online: 18 Oct 2023
AbstractforCCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma | Full Text | References | PDF (15.9 MB)
  • 157 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis [Retraction]
Pages: 839-840
Published online: 20 Oct 2023
CitationforIdentification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis [Retraction] | Full Text | PDF (261.2 KB)
  • 74 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MicroRNA-188-5p Promotes Epithelial–Mesenchymal Transition by Targeting ID4 Through Wnt/β-Catenin Signaling in Retinoblastoma [Retraction]
Pages: 841-842
Published online: 20 Oct 2023
CitationforMicroRNA-188-5p Promotes Epithelial–Mesenchymal Transition by Targeting ID4 Through Wnt/β-Catenin Signaling in Retinoblastoma [Retraction] | Full Text | PDF (284.8 KB)
  • 71 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis [Retraction]
Pages: 843-844
Published online: 20 Oct 2023
CitationforLong Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis [Retraction] | Full Text | PDF (266.1 KB)
  • 75 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
LncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression [Retraction]
Pages: 845-846
Published online: 20 Oct 2023
CitationforLncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression [Retraction] | Full Text | PDF (246.4 KB)
  • 74 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction]
Pages: 847-848
Published online: 20 Oct 2023
CitationforLncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction] | Full Text | PDF (247.5 KB)
  • 75 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies
Yunhe Xie, Jiarong Ye & Hongliang Luo
Pages: 849-865
Published online: 24 Oct 2023
AbstractforHOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies | Full Text | References | PDF (9.2 MB)
  • 170 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy
Xinyi Zhang, Fengxi Li, Rong Li, Nan Zhao, Dianfeng Liu, Yuelin Xu, Lei Wang, Dongxu Wang & Ruihong Zhao
Pages: 867-883
Published online: 27 Oct 2023
AbstractforB7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy | Full Text | References | PDF (11.8 MB)
  • 150 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
Ling Chen, Zhe Meng, Zhiguo Zhou, Xiaomin Li, Liyan Zhao, Zhaohui Jia, Jingli Chen, Ye Tian, Qingju Meng & Yibing Liu
Pages: 885-890
Published online: 30 Oct 2023
AbstractforImmunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer | Full Text | References | PDF (995 KB)
  • 137 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival
Victoriano Mendieta-Carmona, Guadalupe Delgado-López, Julio Reyes-Leyva, Claudia Teresita Gutiérrez-Quiroz, Víctor Javier Vazquez-Zamora, Denisse Alejandra Picazo-Mendoza, Alvaro José Montiel-Jarquín, Laura Patricia Martinez-Morales & Verónica Vallejo-Ruiz
Pages: 891-904
Published online: 31 Oct 2023
AbstractforGalectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival | Full Text | References | PDF (6.2 MB)
  • 185 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review
Zhou Zhu, Na Zhou, Shuangni Yu, Xin Gao, Xin Cheng, Yingyi Wang & Chunmei Bai
Pages: 905-911
Published online: 01 Nov 2023
AbstractforSuccessful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review | Full Text | References | PDF (2.9 MB)
  • 164 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RAPID COMMUNICATION

Rapid Communication
GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells
Xuan Wan, Yuting Fang, Jiangzhou Du, Shaoxi Cai & Hangming Dong
Pages: 913-922
Published online: 07 Nov 2023
AbstractforGW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells | Full Text | References | PDF (5.3 MB)
  • 177 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study
Zhitao Chen, Yahui He, Chenchen Ding, Jun Chen, Yangjun Gu, Min Xiao & Qiyong Li
Pages: 923-935
Published online: 08 Nov 2023
AbstractforSafety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study | Full Text | References | PDF (4.4 MB)
  • 147 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction]
Pages: 937-938
Published online: 09 Nov 2023
CitationformiR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction] | Full Text | PDF (237.4 KB)
  • 74 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Oral Anlotinib Maintenance Therapy for an Advanced Malignant Peritoneal Mesothelioma Diagnosed by Laparoscopy After Initial Misdiagnosis to Obtain Longer Progression-Free Survival: Case Report and Literature Review
Fan-Jie Qu, Yi Zhou & Hai Wang
Pages: 961-972
Published online: 15 Nov 2023
AbstractforOral Anlotinib Maintenance Therapy for an Advanced Malignant Peritoneal Mesothelioma Diagnosed by Laparoscopy After Initial Misdiagnosis to Obtain Longer Progression-Free Survival: Case Report and Literature Review | Full Text | References | PDF (3.1 MB)
  • 146 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study
Yunxiang Zhou, Xianan Guo, Lu Shen, Kexin Liu, Qunan Sun, Yali Wang, Hui Wang, Wenyu Fu, Yihan Yao, Shijie Wu, Huihui Chen, Jili Qiu, Tao Pan & Yongchuan Deng
Pages: 939-960
Published online: 15 Nov 2023
AbstractforPredictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study | Full Text | References | PDF (3.9 MB)
  • 159 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
William G North
Pages: 973-982
Published online: 20 Nov 2023
AbstractforCancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker | Full Text | References | PDF (982.4 KB)
  • 135 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway
Zi-Qi Li, Guo-Song Zhang, Ri-Qun Liu, Shu-Yuan Shuai, Peng-Yi Hu, Qin Zheng & Shu-Hua Xiao
Pages: 983-994
Published online: 21 Nov 2023
AbstractforAnti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway | Full Text | References | PDF (8 MB)
  • 138 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

REVIEW

Review
Optimizing the Continuum of Care in Gastric Cancer
Beatrice Riccò, Giulio Martinelli, Camilla Bardasi, Massimo Dominici, Andrea Spallanzani & Massimiliano Salati
Pages: 995-1012
Published online: 23 Nov 2023
AbstractforOptimizing the Continuum of Care in Gastric Cancer | Full Text | References | PDF (2.5 MB)
  • 171 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer
Yan Huang, Shuang Dai, Wenlian Yin, Feng Luo & Yan Li
Pages: 1015-1020
Published online: 29 Nov 2023
AbstractforSustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer | Full Text | References | PDF (3.7 MB)
  • 117 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction]
Pages: 1013-1014
Published online: 29 Nov 2023
CitationforLncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction] | Full Text | PDF (244.6 KB)
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p [Retraction]
Pages: 1021-1022
Published online: 30 Nov 2023
CitationforHsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p [Retraction] | Full Text | PDF (261 KB)
  • 78 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction]
Pages: 1023-1024
Published online: 06 Dec 2023
CitationforMicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction] | Full Text | PDF (245.3 KB)
  • 77 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction]
Pages: 1025-1026
Published online: 07 Dec 2023
CitationformiR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction] | Full Text | PDF (258.9 KB)
  • 69 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Investigating the Diagnostic and Therapeutic Potential of SREBF2-Related Lipid Metabolism Genes in Colon Cancer
Yuteng Ma, Zhe Wang, Jian Sun, Jingtong Tang, Jianping Zhou & Ming Dong
Pages: 1027-1042
Published online: 12 Dec 2023
AbstractforInvestigating the Diagnostic and Therapeutic Potential of SREBF2-Related Lipid Metabolism Genes in Colon Cancer | Full Text | References | PDF (11.3 MB)
  • 158 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Epithelioid Subtype Gastrointestinal Stromal Tumors of Stomach in an Endoscopic Biopsy: A Potential Diagnostic Pitfall
Wenfeng Xu, Hao Tang, Ying Chen, Jiashuang Wang, Zhongjiao Chen, Yujuan Xu & Deyu Guo
Pages: 1043-1049
Published online: 12 Dec 2023
AbstractforEpithelioid Subtype Gastrointestinal Stromal Tumors of Stomach in an Endoscopic Biopsy: A Potential Diagnostic Pitfall | Full Text | References | PDF (1.1 MB)
  • 130 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction]
Pages: 1053-1054
Published online: 15 Dec 2023
CitationforST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction] | Full Text | PDF (244.2 KB)
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Retraction
MLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer [Retraction]
Pages: 1051-1052
Published online: 15 Dec 2023
CitationforMLPH Accelerates the Epithelial–Mesenchymal Transition in Prostate Cancer [Retraction] | Full Text | PDF (236.1 KB)
  • 61 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

CASE REPORT

Case Report
Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report
Xiaoli Zhao, Mengze Hao, Xiaoyu Zhang, Jialin Wei, Sizhou Feng, Yi He, Erlie Jiang & Mingzhe Han
Pages: 1055-1059
Published online: 17 Dec 2023
AbstractforPost-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report | Full Text | References | PDF (976.6 KB)
  • 85 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

ORIGINAL RESEARCH

Article
Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib
Anqing Zhang, Liqin Zhang, Xia Xie & Dan Liu
Pages: 1061-1071
Published online: 18 Dec 2023
AbstractforInhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib | Full Text | References | PDF (6.5 MB)
  • 197 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

RETRACTION

Retraction
The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer [Retraction]
Pages: 1073-1074
Published online: 23 Dec 2023
CitationforThe LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer [Retraction] | Full Text | PDF (280.5 KB)
  • 55 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles